Results 121 to 130 of about 2,643,317 (205)
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia
We report a new chromosomal reciprocal translocation t(5;10)(q33;q22) in a 49-year-old man with atypical chronic myeloid leukemia (a-CML) and history of occupational exposure to petroleum products including benzene and other hydrocarbons.
S Siena +8 more
doaj
Information on the outcome of allogeneic bone marrow transplant (BMT) for chronic myeloid leukaemia (CML) was previously provided by BMT centres or registries.
The Italian Cooperative Study Group on Chronic Myeloid Leukemia +1 more
core
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by bone marrow expansion and the proliferation of one or more myeloid cell lineages, predominantly driven by the expression of the constitutively active fusion product tyrosine
Alessandra Mongia +7 more
doaj +1 more source
BACKGROUND AND OBJECTIVE: Alpha-interferon (alphaIFN) can induce cytogenetic remissions in chronic myeloid leukemia (CML). Hemopoietic progenitors can be collected from the marrow in remission and utilized for autologous repopulation after high dose ...
Russo D +13 more
core
Abnormalities affecting tyrosine kinase signalling in atypical myeloproliferative disorders [PDF]
The myeloproliferative disorders (MPDs) are a group of haematopoietic stem cell diseases, characterised by proliferation of one or more cells of the myeloid lineage.
Hidalgo-Curtis, Claire
core
A 19-year-old patient with atypical chronic myeloid leukemia. [PDF]
Ernst P +12 more
europepmc +1 more source
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia.
Pietro Poggio +18 more
doaj +1 more source
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors [PDF]
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835) point mutations, are present in approximately one third of patients with acute myeloid leukemia (AML) and have been associated with an increased relapse rate.
Kottaridis, P.D. +5 more
core
Decitabine combined with CAG for the treatment of atypical chronic myeloid leukemia: a case report and literature review. [PDF]
Cheng J, Zhang H, Ma HZ.
europepmc +1 more source

